2008
DOI: 10.1542/peds.2007-2022aaa
|View full text |Cite
|
Sign up to set email alerts
|

TEL/AML1+ ACUTE LYMPHOBLASTIC LEUKEMIA IN THE GREEK PEDIATRIC POPULATION

Abstract: INTRODUCTION:Various pathways, such as personperson, fecal-oral, and oral-oral transmission, play a role in transmission of Helicobacter pylori infection. It can be transferred from mother to infant in either the perinatal or postnatal periods. OBJECTIVE: The aim of this prospective study was to determine the course of H pylori infection in motherinfant pairs in early years of life. METHODS: Forty-eight mother-child pairs were followed for 12 months. H pylori and hepatitis A virus immunoglobulin G levels were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In United States this is estimated to be 17-25% among pediatric patients (Loh et al, 1998;Jamil et al, 2000). The incidence of TEL-AML1 fusion in 334 Italian and German children with ALL was 18.9% (Borkhardt et al, 1997) and 22-27% in German children alone (Papadhimitriou et al, 2008), as compared to 22.5% in 617 children from UK (Harrison, 2000). Similarly the prevalence of TEL-AML1 transcript in acute lymphoblastic leukemia patients in Serbia is 17.1% (Lazic et al, 2010) and 20% in Brazil (Magalhaes et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…In United States this is estimated to be 17-25% among pediatric patients (Loh et al, 1998;Jamil et al, 2000). The incidence of TEL-AML1 fusion in 334 Italian and German children with ALL was 18.9% (Borkhardt et al, 1997) and 22-27% in German children alone (Papadhimitriou et al, 2008), as compared to 22.5% in 617 children from UK (Harrison, 2000). Similarly the prevalence of TEL-AML1 transcript in acute lymphoblastic leukemia patients in Serbia is 17.1% (Lazic et al, 2010) and 20% in Brazil (Magalhaes et al, 2000).…”
Section: Discussionmentioning
confidence: 99%